Offer - Urjas Oil for just ₹ 1 X
Diprobate ES plus is an allopathic medicine The correct dosage of Diprobate ES plus depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Diprobate ES plus is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Diprobate ES plus safe for pregnant women?
No research has not been done till date on the safety of Diprobate ES plus for pregnant women. So its effects on pregnant women are unknown.
Is the use of Diprobate ES plus safe during breastfeeding?
Information about safety of Diprobate ES plus for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Diprobate ES plus on the Kidneys?
Very few cases of side effects of Diprobate ES plus on kidney have been reported.
What is the effect of Diprobate ES plus on the Liver?
In the absence of any scientific study on the side effects of Diprobate ES plus on the liver, information on safety of Diprobate ES plus for liver is unavailable.
What is the effect of Diprobate ES plus on the Heart?
Very few cases of side effects of Diprobate ES plus on the heart have been reported.
Diprobate ES plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Diprobate ES plus unless your doctor advises you to do so -
Is this Diprobate ES plus habit forming or addictive?
No, there is no any evidence that Diprobate ES plus is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Diprobate ES plus since it will not make you feel sleepy.
Is it safe?
Diprobate ES plus is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Diprobate ES plus is unable to treat or cure mental disorders.
Interaction between Food and Diprobate ES plus
Due to the absence of research, it is difficult to say how Diprobate ES plus and food will interact.
Interaction between Alcohol and Diprobate ES plus
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Diprobate ES plus.
Yes, Diprobate ES plus can cause constipation. It is a common side effect of this drug. However, if you are experiencing any unpleasant effects after taking this medicine, please consult your doctor right away and follow his/her instructions.
Yes, long-term use of Diprobate ES plus may cause low potassium level in your body by increasing the excretion of potassium in the urine. This can result in symptoms such as muscle cramps, weakness, tiredness, and an irregular heartbeat.
Yes, Diprobate ES plus is used in the treatment of gastritis. It is presumed that Diprobate ES plus works in gastritis by suppressing the immune response which causes inflammation and additionally relieving the symptoms of gastritis such as stomach pain, stomach inflammation, and acid reflux.
Diprobate ES plus if taken in tablet form might cause hiccups, but it has been mainly associated with patients who received chemotherapy.
Yes, Diprobate ES plus is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at therapeutic doses such as fluid retention (swelling in your hands or ankles), increased appetite, increased sweating, and stomach upset. Do not hesitate to inform your doctor if you are facing any of the above.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 902
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 902
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zinc Sulfate (zinc sulfate)